Literature DB >> 21054561

Absence of merkel cell polyoma virus in cutaneous melanoma.

Ivette Koburger, Diana Meckbach, Gisela Metzler, Uwe Fauser, Claus Garbe, Jürgen Bauer.   

Abstract

Recently, merkel cell polyoma virus (MCPyV) has been described in 80% of merkel cell carcinomas (MCC). Similar to MCC, melanoma incidence is increased in immuno-suppressed patients. We hypothesized that MCPyV may play a role in melanoma development as well. We selected 95 archival, paraffin-embedded primary melanomas. DNA was obtained from micro-dissected tissue and amplified with PCR primer sets specific for the MCPyV T-antigen locus (LT1 and LT3) and for the VP1 gene. None of the 95 melanoma samples did show LT1, LT3, or VP1 fragment amplification. In conclusion, there is no evidence that MCPyV infection plays a role in cutaneous melanoma development.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054561     DOI: 10.1111/j.1600-0625.2010.01175.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  4 in total

1.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

2.  Molecular Profiling of Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma and Cutaneous Melanoma.

Authors:  Attila Mokánszki; Gábor Méhes; Szilvia Lilla Csoma; Sándor Kollár; Yi-Che Chang Chien
Journal:  Diagnostics (Basel)       Date:  2021-02-01

Review 3.  The Human Microbiota and Skin Cancer.

Authors:  Yu Ri Woo; Sang Hyun Cho; Jeong Deuk Lee; Hei Sung Kim
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

4.  Merkel cell carcinoma in immunosuppressed patients.

Authors:  Janice E Ma; Jerry D Brewer
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.